ABIVAX Société Anonyme recently reported that its lead drug candidate, obefazimod, delivered positive Phase 3 results in ulcerative colitis, meeting key secondary endpoints with a clean safety profile ...
Fintel on MSN
ABIVAX Société Anonyme - Depositary receipt (ABVX) price target increased by 13.41% to 152.58
The average one-year price target for ABIVAX Société Anonyme - Depositary Receipt (NasdaqGM:ABVX) has been revised to $152.58 ...
We came across a bullish thesis on ABIVAX Société Anonyme on Alpha Talon Investment Research’s Substack by AT Investment ...
ABIVAX Société Anonyme (NASDAQ:ABVX) is one of the 11 Best Performing Stocks in the Last 12 Months. For the past couple of ...
Zacks.com on MSN
Here's Why Abivax SA Sponsored ADR (ABVX) is Poised for a Turnaround After Losing -19.81% in 4 Weeks
Abivax SA Sponsored ADR (ABVX) has been on a downward spiral lately with significant selling pressure. After declining 19.8% ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
We recently published 10 Market Stars Behind Millionaire-Making in 2025. ABIVAX Societe Anonyme (NASDAQ:ABVX) is last year’s top performer. Abivax skyrocketed by 1,742.28 percent in 2025, as investor ...
Investors with a lot of money to spend have taken a bearish stance on Abivax (NASDAQ:ABVX). And retail traders should know. We noticed this today when the positions showed up on publicly available ...
(RTTNews) - Shares of Abivax SA (ABVX) are trading at an all-time high of $80, thanks to the recently announced encouraging clinical trial results for its experimental ulcerative colitis drug, ...
Investors with a lot of money to spend have taken a bearish stance on Abivax (NASDAQ:ABVX). And retail traders should know. We noticed this today when the positions showed up on publicly available ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results